Investor Relations Overview
Printer Friendly Version Print | E-mail this page E-mail | E-mail Alerts Alerts | View contacts Contacts | Download Financial Tear Sheet Tear Sheet
Webcast ImageWebcast
Q1 2014 CryoLife, Inc. Earnings Conference Call (Live)
04/29/14 at 10:00 a.m. ET
Fortune Small Business
Congratulates CryoLife for making the 2009 hot list of the fastest-growing firms in America!
More>>

Corporate Profile

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the U.S. and Canada. CryoLife's CryoValve® SG pulmonary heart valve, processed using CryoLife's proprietary SynerGraft® technology, has FDA 510(k) clearance for the replacement of diseased, damaged, malformed, or malfunctioning native or prosthetic pulmonary valves. CryoLife's CryoPatch® SG pulmonary cardiac patch has FDA 510(k) clearance for the repair or reconstruction of the right ventricular outflow tract (RVOT), which is a surgery commonly performed in children with congenital heart defects, such as Tetralogy of Fallot, Truncus Arteriosus, and Pulmonary Atresia.  More >>

CRY (Common Stock)
ExchangeNYSE (US Dollar)
Price$9.81
Change (%) Stock is Up 0.06 (0.62%)
Volume84,836
04/16/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Annual Meeting Materials
2009 Annual Report - Adobe PDF2013 Annual Report
Proxy Statement and Notice of Annual Meeting - Adobe PDFProxy Statement and Notice of Annual Meeting
Proxy Card - Adobe PDFProxy Card
Recent NewsMore >>
DateTitle
04/15/14CryoLife Announces Release Date and Teleconference Call Details for 2014 First Quarter Financial Results
04/02/14CryoLife Receives FDA Approval to Begin Clinical Trials for PerClot® in the U.S.
03/27/14CryoLife Acquires Distribution Rights and Purchase Option for ProCol® Vascular Bioprosthesis for Hemodialysis Access
Reconciliation for Certain Items
DownloadTitle
Non-GAAP Reconciliation of Free Cash Flow
Non-GAAP Reconciliation of Adjusted Net Income
Upcoming EventsMore >>
DateTitle
04/29/14 10:00 a.m. ET
Q1 2014 CryoLife, Inc. Earnings Conference Call
Most Recent SEC FilingsMore >>
Filing DateFormFiling GroupDownloads
04/08/14DEF 14AProxy Filings Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
04/08/148-KCurrent Reports Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
03/31/148-KCurrent Reports Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
03/10/1443,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
03/10/1443,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.